Bernafon Spain A.I CyberSecurity Scoring
31/01/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Bernafon Spain in 2026.
No incidents recorded for Bernafon Spain in 2026.
No incidents recorded for Bernafon Spain in 2026.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
As a leading medical technology company, B. Braun protects and improves the health of people around the world. For more than 185 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits. More than 64,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops integrated solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2024, the B. Braun Group generated sales of € 9.1 billion. Imprint: https://www.bbraun.com/en/imprint.html Privacy Policy: https://www.bbraun.com/en/privacy-policy.html
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can-do attitude, we work together to win.. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited. Please note: not all products referred to may be approved for use or available in all markets.
Latest updates, reports, and threat intel affecting the global network.
OliveTin gives access to predefined shell commands from a web interface. The `filterToDefinedArgumentsOnly` function in the executor is intended to discard any arguments not explicitly defined in the action's configuration. However, prior to commit ebffd9f040f791208aee1db2e5a8aecd1e3e603d, a special case allows any argument whose name starts with `ot_` to bypass this filter. While two system arguments (`ot_executionTrackingId` and `ot_username`) are injected by OliveTin and overridden, all other `ot_`-prefixed arguments supplied by the user pass through unmodified. These bypassed arguments are not type-checked — the validation loop only iterates over the action's defined arguments, so `ot_`-prefixed arguments skip all type safety checks entirely; set as environment variables — via `buildEnv()`, with completely unvalidated values, and passed to the executed command; and included in the template context — available as `.Arguments.ot_*` in template rendering. Commit ebffd9f040f791208aee1db2e5a8aecd1e3e603d contains a patch.
WeeChat (Wee Enhanced Environment for Chat) is a free chat client. In versions 0.3.1 through 4.9.0, the WeeChat relay authentication uses non-constant-time string comparison functions (weechat_strcasecmp and strcmp) to verify password hashes and plaintext passwords. An attacker can exploit timing differences to extract the server-computed hash character by character, then authenticate using the correct hash without knowing the password. Version 4.9.1 fixes the issue.
WeeChat (Wee Enhanced Environment for Chat) is a free chat client. In versions 4.3.0 through 4.9.0, the WeeChat relay module's WebSocket permessage-deflate decompression function relay_websocket_inflate() has no upper bound on output size. An authenticated relay user can send a small compressed WebSocket frame (~100 bytes) that decompresses to gigabytes, exhausting all server memory and crashing the entire WeeChat process. The api protocol enables permessage-deflate and requires authentication before WebSocket upgrade. Version 4.9.1 patches the issue.
FORT Validator is a Resource Public Key Infrastructure (RPKI) relying-party validator that produces validated route-origin data. FORT Validator versions through 1.6.7 contain an origin-validation error in their RRDP processing: a delegated CA under the same Trust Anchor Locator (TAL) can reference a victim CA’s public RRDP notification and snapshot URLs, causing FORT’s URL-based download cache to report success after deleting the victim’s local snapshot. Following a routine victim publication, this can silently remove the victim’s VRPs and other signed objects from FORT’s output, potentially enabling route hijacking or loss of reachability. Version 1.6.8 contains a patch that rejects cross-origin RRDP snapshot and delta URLs; as a workaround, administrators can disable HTTP/RRDP with --http.enabled=false while keeping rsync enabled, although this can leave data unavailable or stale where rsync is not supported.
Recce is a data-validation toolkit for enhanced dbt (data build tool) PR review. Prior to version 1.50.0, OSS server deployments that expose the server to an untrusted network without authentication are vulnerable to unauthenticated SQL execution through the query run API. When Recce is configured with a DuckDB-backed project, an attacker can use DuckDB filesystem primitives to read and write files accessible to the Recce server process. The impact depends on how Recce is deployed, but may include disclosure of local files, tampering with Recce/dbt artifacts, modification of browser-served static files leading to stored XSS, and modification of application files if those paths are writable. If Recce is run as root, file access occurs with root privileges inside that host or container. This issue has been patched in Recce `v1.50.0`. Users should upgrade to Recce `v1.50.0` or later. The patch restricts unsafe file read/write behavior for DuckDB-backed query execution and hardens the affected query path. Other warehouse adapters have also been reviewed for similar exposure. Users who cannot upgrade immediately should avoid exposing `recce server` to the public internet or any untrusted network. Recommended mitigations include enabling authentication or placing Recce behind an authenticated reverse proxy/VPN, running Recce as a non-root user, using a read-only application filesystem where possible, and ensuring that sensitive files or credentials are not available to the Recce process.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.